G0S2 and chronic myelogenous leukemia, BCR-ABL1 positive: To assess the in vivo effects of G0s2 loss in CML, we utilised lineage‐negative BM from wild‐type versus G0s2−/− mice, and performed a retroviral transduction/transplantation assay that mimics BP‐CML.